ArticleNature communications2026
Data-driven construction of an imine reductase library capable of broad-scope reductive amination at equimolar substrate concentrations.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Data-driven construction of an imine reductase library capable of broad-scope reductive amination at equimolar substrate concentrations.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reductive amination catalysed by imine reductases and reductive aminases has emerged as a powerful method for the asymmetric synthesis of chiral amines, yet the generality and practical limitations of these enzymes remain poorly understood. Here, we combine large-scale, iterative activity screening, sequence analysis and machine-learning-guided exploration to systematically profile reductive amination performance across 175 enzymes and structurally diverse substrate panels. We show that asymmetric reductive amination at equimolar substrate concentrations is widespread within this enzyme family and assemble catalysts that display broad scope, high specific activity and excellent stereoselectivity. Sequence-level analysis identifies characteristic features associated with broad-scope reductive aminases and pinpoints key residues governing stereoselectivity, while machine-learning models trained on the screening data enable successful prediction of enzyme activity for previously untested substrate combinations. Selected reactions were scaled to a preparative batch size, affording gram quantities of optically pure amine products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.